{
  "tool": "tavily",
  "query": "abridge last_disclosed_valuation_usd",
  "results": [
    {
      "title": "In just 4 months, AI medical scribe Abridge doubles valuation to $5.3B",
      "content": "# In just 4 months, AI medical scribe Abridge doubles valuation to $5.3B Abridge, an AI startup automating medical notes, has secured a $300 million Series E at a $5.3 billion valuation, according to the Wall Street Journal. The 7-year-old Abridge is widely considered to be the leader in the increasingly crowded AI-powered medical scribe market, largely due to its early entryand integration with Epic Systems, the dominant health record software. Along with the fundraise, Abridge announced that it is expanding into converting medical notes from patient appointments into AI-powered medical codes, an offering that makes the company directly competitive with startups like CodaMetrix and a feature from its partner Epic Systems. a16z, Abridge, AI, AI note-taking, Biotech & Health, In Brief, Startups",
      "url": "https://techcrunch.com/2025/06/24/in-just-4-months-ai-medical-scribe-abridge-doubles-valuation-to-5-3b/"
    },
    {
      "title": "Healthcare startup Abridge tops $5 billion valuation in A16z-led ...",
      "content": "Healthcare firm Abridge, which uses artificial intelligence to build medical documents, has raised $300 million at a $5.3 billion valuation,",
      "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/healthcare-startup-abridge-raises-300-million-led-by-vc-firm-andreessen-horowitz-2025-06-24/"
    },
    {
      "title": "Abridge secures $300M, boosts valuation to $5.3B | MobiHealthNews",
      "content": "The Series E funding comes four months after the company secured $250 million in a Series D round. Abridge, a generative AI platform for clinical conversations, has raised $300 million in Series E funding, bringing its valuation to a reported $5.3 billion. In February, Abridge raised $250 million in Series D funding, bringing its valuation at the time to $2.75 billion. Other companies in the AI medical documentation space include Commure, which last week raised $200 million in growth funding from General Catalyst's Customer Value Fund. In October, Suki, maker of an AI-enabled voice tool for healthcare, raised $70 million in Series D funding, bringing its total raise to $165 million.",
      "url": "https://www.mobihealthnews.com/news/abridge-secures-300m-boosts-valuation-53b"
    },
    {
      "title": "Abridge closes $300M in series E funding, hits $5.3B valuation",
      "content": "Abridge closes $300M in series E funding, hits $5.3B valuation - Becker's Hospital Review | Healthcare News & Analysis *   Health IT *   Health IT *   Health IT *   Health IT *   Health IT *   Click to share on LinkedIn (Opens in new window) Abridge, which provides ambient listening technology for clinical documentation to more than 150 health systems, has raised $300 million to bring its valuation to $5.3 billion. Philadelphia-based Jefferson Health has gone live with Epic\u2019s MyChart Central, a tool that allows patients to securely access their health\u2026 By:Naomi Diaz 6 hours ago     As health systems await a federal funding solution for hospital at home amid the government shutdown, healthcare organizations are mixed\u2026 By:Giles Bruce 6 hours ago    ",
      "url": "https://www.beckershospitalreview.com/healthcare-information-technology/innovation/abridge-closes-300m-in-series-e-funding-hits-5-3b-valuation/"
    },
    {
      "title": "Media Reactions to Abridge's Next Chapter: Series E",
      "content": "Your Abridge report has been sent to your email. Abridge This week, Abridge announced a $300 million Series E funding round, led by a16z and joined by Khosla Ventures and other leading investors. (*Generative AI company Abridge scores $300M series E backed by a16z and Khosla Ventures* \u2013 Fierce Healthcare, 6/24) (*With a $5.3B valuation, Abridge sends a message: Note-taking was just the start* \u2013 Becker\u2019s Hospital Review, 6/25) (*Abridge, Whose AI App Takes Notes for Doctors, Valued at $5.3 Billion at Funding* \u2013 WSJ, 6/24) \u201cThe 7-year-old Abridge is widely considered to be the leader in the increasingly crowded AI-powered medical scribe market.\u201d (*In just 4 months, AI medical scribe Abridge doubles valuation to $5.3B* \u2013 TechCrunch, 6/24) ## Abridge Abridge",
      "url": "https://www.abridge.com/blog/series-e-media-recap"
    }
  ],
  "raw_content": "\nIn just 4 months, AI medical scribe Abridge doubles valuation to $5.3B\n# In just 4 months, AI medical scribe Abridge doubles valuation to $5.3B Abridge, an AI startup automating medical notes, has secured a $300 million Series E at a $5.3 billion valuation, according to the Wall Street Journal. The 7-year-old Abridge is widely considered to be the leader in the increasingly crowded AI-powered medical scribe market, largely due to its early entryand integration with Epic Systems, the dominant health record software. Along with the fundraise, Abridge announced that it is expanding into converting medical notes from patient appointments into AI-powered medical codes, an offering that makes the company directly competitive with startups like CodaMetrix and a feature from its partner Epic Systems. a16z, Abridge, AI, AI note-taking, Biotech & Health, In Brief, Startups\n\nHealthcare startup Abridge tops $5 billion valuation in A16z-led ...\nHealthcare firm Abridge, which uses artificial intelligence to build medical documents, has raised $300 million at a $5.3 billion valuation,\n\nAbridge secures $300M, boosts valuation to $5.3B | MobiHealthNews\nThe Series E funding comes four months after the company secured $250 million in a Series D round. Abridge, a generative AI platform for clinical conversations, has raised $300 million in Series E funding, bringing its valuation to a reported $5.3 billion. In February, Abridge raised $250 million in Series D funding, bringing its valuation at the time to $2.75 billion. Other companies in the AI medical documentation space include Commure, which last week raised $200 million in growth funding from General Catalyst's Customer Value Fund. In October, Suki, maker of an AI-enabled voice tool for healthcare, raised $70 million in Series D funding, bringing its total raise to $165 million.\n\nAbridge closes $300M in series E funding, hits $5.3B valuation\nAbridge closes $300M in series E funding, hits $5.3B valuation - Becker's Hospital Review | Healthcare News & Analysis *   Health IT *   Health IT *   Health IT *   Health IT *   Health IT *   Click to share on LinkedIn (Opens in new window) Abridge, which provides ambient listening technology for clinical documentation to more than 150 health systems, has raised $300 million to bring its valuation to $5.3 billion. Philadelphia-based Jefferson Health has gone live with Epic\u2019s MyChart Central, a tool that allows patients to securely access their health\u2026 By:Naomi Diaz 6 hours ago     As health systems await a federal funding solution for hospital at home amid the government shutdown, healthcare organizations are mixed\u2026 By:Giles Bruce 6 hours ago    \n\nMedia Reactions to Abridge's Next Chapter: Series E\nYour Abridge report has been sent to your email. Abridge This week, Abridge announced a $300 million Series E funding round, led by a16z and joined by Khosla Ventures and other leading investors. (*Generative AI company Abridge scores $300M series E backed by a16z and Khosla Ventures* \u2013 Fierce Healthcare, 6/24) (*With a $5.3B valuation, Abridge sends a message: Note-taking was just the start* \u2013 Becker\u2019s Hospital Review, 6/25) (*Abridge, Whose AI App Takes Notes for Doctors, Valued at $5.3 Billion at Funding* \u2013 WSJ, 6/24) \u201cThe 7-year-old Abridge is widely considered to be the leader in the increasingly crowded AI-powered medical scribe market.\u201d (*In just 4 months, AI medical scribe Abridge doubles valuation to $5.3B* \u2013 TechCrunch, 6/24) ## Abridge Abridge\n",
  "count": 5,
  "success": true
}